OrbiMed Capital GP VIII LLC
SEC CIK 1845804 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SION | Sionna Therapeutics, Inc. | Dir | 3.53M | $9.90M | $2.95M | 5 | 2025-02-10 | 2026-02-02 |
Most active insiders at SION, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Thompson Peter A. | Dir | — | $55.67M |
| 2 | ORBIMED ADVISORS LLC | Dir | — | $52.73M |
| 3 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | — | $27.34M |
| 4 | Booth Bruce | Dir | — | $22.09M |
| 5 | RA Capital Nexus Fund III, L.P. | Dir | — | $14.76M |
| 6 | WINKELRIED JON | 10% | — | $10.00M |
| 7 | Cloonan Michael | Pres, CEO, Dir | — | $5.13M |
| 8 | OrbiMed Capital GP VIII LLC | Dir | — | $2.95M |
| 9 | Fitzpatrick Jennifer | CLO, Head of Program Mgmt | — | $1.21M |
| 10 | Kolchinsky Peter | Dir, 10% | — | $1.20M |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-02-04 | 2026-02-02+ | SION | Sionna Therapeutics, Inc. | OrbiMed Capital GP VIII LLC | Dir | S - Sale | $44.58 | -31.0K | 3.53M | -0.9% | -$1.38M |
| I | 2025-12-29 | 2025-12-24 | SION | Sionna Therapeutics, Inc. | OrbiMed Capital GP VIII LLC | Dir | S - Sale | $44.55 | -33.4K | 3.56M | -0.9% | -$1.49M |
| MI | 2025-12-19 | 2025-12-17+ | SION | Sionna Therapeutics, Inc. | OrbiMed Capital GP VIII LLC | Dir | S - Sale | $44.49 | -1,875 | 3.60M | -0.1% | -$83.4K |
| DI | 2025-02-10 | 2025-02-10 | SION | Sionna Therapeutics, Inc. | OrbiMed Capital GP VIII LLC | Dir | C - Cnv Deriv | — | +3.15M | 3.15M | New | — |
| DI | 2025-02-10 | 2025-02-10 | SION | Sionna Therapeutics, Inc. | OrbiMed Capital GP VIII LLC | Dir | P - Purchase | $18.00 | +550.0K | 3.70M | +17% | +$9.90M |
Purchase Sale Sale after option exercise All abbreviations